Skip to content

American Vanguard AVD Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses

Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
48.5%

Other financials

Income statement

See full
Revenue$123.6M+6.7%
Gross profit$38.4M+27.2%
Operating income$1.9M+144%
Net income-$4.1M+51.0%
EPS (diluted)-$0.14+53.3%

Balance sheet

See full
Cash & equivalents$70.9M+501%
Total debt$283.1M+51.8%
Total assets$665.2M+5.3%

Cash flow

See full
Operating cash flow-$35.4M-72.2%
CapEx$971.0K+125%
Free cash flow-$36.4M-73.3%

Valuation

See full
Market cap$80.1M-15.1%
Enterprise value$292.32M+0.7%
P/S0.2×0.0×

Profitability

See full
Gross margin29.8%+9.3pp
Operating margin-4.2%-1.9pp
Net margin-8.7%-3.5pp
FCF margin-9.9%-14.9pp

Returns & leverage

See full
Return on equity7.6%
Debt / equity0.3×
Current ratio2.3×+0.5×